Fairbank Counseling, Pllc | |
2 6th Ave E Polson MT 59860-2726 | |
(406) 214-3137 | |
Not Available |
Full Name | Fairbank Counseling, Pllc |
---|---|
Speciality | Social Worker |
Location | 2 6th Ave E, Polson, Montana |
Authorized Official Name and Position | Coyote Fairbank (OWNER) |
Authorized Official Contact | 4062143137 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Fairbank Counseling, Pllc Po Box 181 Polson MT 59860-0181 Ph: (406) 214-3137 | Fairbank Counseling, Pllc 2 6th Ave E Polson MT 59860-2726 Ph: (406) 214-3137 |
NPI Number | 1396410130 |
---|---|
Provider Enumeration Date | 08/13/2021 |
Last Update Date | 08/13/2021 |
Certification Date | 08/13/2021 |
Medicare PECOS PAC ID | 0446642011 |
---|---|
Medicare Enrollment ID | O20220112001433 |
News Archive
Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, today reported financial results for the second quarter ended June 30, 2009.
Researchers from the Department of Psychiatry at the University of Cambridge recently identified a method of improving cognitive functioning in patients with schizophrenia, without the side-effects traditionally found with cognitive enhancers. Ms. Danielle Turner, together with colleagues from the University of Cambridge under the supervision of Prof. Barbara Sahakian, undertook research to explore the potential for a memory drug to improve cognition in patients with schizophrenia. The project received funding from the Wellcome Trust and the Medical Research Council. The work was published online on March 10 2004 at The American College of Neuropsychopharmacology website and is now in press in the journal Neuropsychopharmacology.
Early postpartum visits with pediatricians may help prevent a dangerous complication associated with jaundice, according to the presentation, "Inadequate Attention Given to Jaundice in Healthy Term Infants during the First Postpartum Week."
NHS doctors are in trouble for over use of diagnostic genetic tests as these infringe upon patents. The British law now recognizes patents on the application of DNA discoveries. But doctors developing genetic tests in NHS hospitals tend to pay no heed to intellectual property.
› Verified 1 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1396410130 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
Provider Name | Coyote Kyle Wayne Fairbank |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1447783170 PECOS PAC ID: 4183901531 Enrollment ID: I20170511002801 |
News Archive
Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, today reported financial results for the second quarter ended June 30, 2009.
Researchers from the Department of Psychiatry at the University of Cambridge recently identified a method of improving cognitive functioning in patients with schizophrenia, without the side-effects traditionally found with cognitive enhancers. Ms. Danielle Turner, together with colleagues from the University of Cambridge under the supervision of Prof. Barbara Sahakian, undertook research to explore the potential for a memory drug to improve cognition in patients with schizophrenia. The project received funding from the Wellcome Trust and the Medical Research Council. The work was published online on March 10 2004 at The American College of Neuropsychopharmacology website and is now in press in the journal Neuropsychopharmacology.
Early postpartum visits with pediatricians may help prevent a dangerous complication associated with jaundice, according to the presentation, "Inadequate Attention Given to Jaundice in Healthy Term Infants during the First Postpartum Week."
NHS doctors are in trouble for over use of diagnostic genetic tests as these infringe upon patents. The British law now recognizes patents on the application of DNA discoveries. But doctors developing genetic tests in NHS hospitals tend to pay no heed to intellectual property.
› Verified 1 days ago
Provider Name | Shaina Lynn Fairbank |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1164198826 PECOS PAC ID: 8426444217 Enrollment ID: I20220404001538 |
News Archive
Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, today reported financial results for the second quarter ended June 30, 2009.
Researchers from the Department of Psychiatry at the University of Cambridge recently identified a method of improving cognitive functioning in patients with schizophrenia, without the side-effects traditionally found with cognitive enhancers. Ms. Danielle Turner, together with colleagues from the University of Cambridge under the supervision of Prof. Barbara Sahakian, undertook research to explore the potential for a memory drug to improve cognition in patients with schizophrenia. The project received funding from the Wellcome Trust and the Medical Research Council. The work was published online on March 10 2004 at The American College of Neuropsychopharmacology website and is now in press in the journal Neuropsychopharmacology.
Early postpartum visits with pediatricians may help prevent a dangerous complication associated with jaundice, according to the presentation, "Inadequate Attention Given to Jaundice in Healthy Term Infants during the First Postpartum Week."
NHS doctors are in trouble for over use of diagnostic genetic tests as these infringe upon patents. The British law now recognizes patents on the application of DNA discoveries. But doctors developing genetic tests in NHS hospitals tend to pay no heed to intellectual property.
› Verified 1 days ago
News Archive
Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, today reported financial results for the second quarter ended June 30, 2009.
Researchers from the Department of Psychiatry at the University of Cambridge recently identified a method of improving cognitive functioning in patients with schizophrenia, without the side-effects traditionally found with cognitive enhancers. Ms. Danielle Turner, together with colleagues from the University of Cambridge under the supervision of Prof. Barbara Sahakian, undertook research to explore the potential for a memory drug to improve cognition in patients with schizophrenia. The project received funding from the Wellcome Trust and the Medical Research Council. The work was published online on March 10 2004 at The American College of Neuropsychopharmacology website and is now in press in the journal Neuropsychopharmacology.
Early postpartum visits with pediatricians may help prevent a dangerous complication associated with jaundice, according to the presentation, "Inadequate Attention Given to Jaundice in Healthy Term Infants during the First Postpartum Week."
NHS doctors are in trouble for over use of diagnostic genetic tests as these infringe upon patents. The British law now recognizes patents on the application of DNA discoveries. But doctors developing genetic tests in NHS hospitals tend to pay no heed to intellectual property.
› Verified 1 days ago
Willow Canyon Counseling Services Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 302 1st St W Ste 203, Polson, MT 59860 Phone: 406-270-3447 | |
Jade Creek Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2 6th Ave E, Polson, MT 59860 Phone: 360-672-1548 | |
Montana Therapy And Consulting Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 105 4th Ave E, Polson, MT 59860 Phone: 406-412-6768 | |
New Mercies 247 Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 32310 Sunrise Dr, Polson, MT 59860 Phone: 406-880-6327 | |
Darci Jones, Lcsw, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 220 Main St, Polson, MT 59860 Phone: 406-885-1188 | |
Montana Psychiatry Consultation Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 500 Mission View Dr, Polson, MT 59860 Phone: 406-552-7799 |